4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-125318
Chief Financial Officer gave up 5,311 shares (to pay taxes)
- Chief Financial Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roche Corleen M. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-06 | Exercise or conversion : show line 1 in the form | +12,500 | 41,257 | D | ||
| 2026-11-06 | Shares withheld for taxes : show line 2 in the form | −5,311 | $8.04 | $42,700 | 35,946 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-06 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −12,500 | 87,505 | D |
Loading xslF345X06/tm2629446-1_4seq1.xml…